| Articolul precedent |
| Articolul urmator |
 |
 215 0 |
 SM ISO690:2012AUTOR, Nou, MAZUR, Lilia, AUTOR, Nou, AUTOR, Nou, AUTOR, Nou, AUTOR, Nou. Indicators of diabetes mellitus type 2 patients compensation by the level of glycated hemoglobin in ternopol region, Ukraine, 2011. In: MedEspera, Ed. 1, 17 mai 2012, Chişinău. Chişinău: "Tipografia-Sirius" SRL, 2012, p. 60. ISBN 978-9975-57-030-5. |
| EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
| MedEspera 2012 | ||||||
|
Conferința "MedEspera" 1, Chişinău, Moldova, 17 mai 2012 | ||||||
|
||||||
| Pag. 60-60 | ||||||
|
||||||
 Descarcă PDF |
||||||
| Rezumat | ||||||
Introduction: WHO notes that diabetes mellitus (DM) leads to increased mortality of patients by 2-3 times and reduces their life duration by 10-30 %. Epidemiological studies in Ukraine indicate a permanent increase in the number of patients with both DM types. The most objective and long-term indicator of diabetes compensation is glycated hemoglobin (HbA1c). Purpose: Our study was to estimate the stage of compensation for patients with DM types 1 and 2 in Ternopil region on the basis of HbA1c levels. Materials and methods: We examined 285 patients with type 2 diabetes, among them 150 people received insulin therapy. The duration of diabetes was from 2 to 17 years. Patients’ age was from 42 to 75 years. Due to the fact that the study involved 49.2% of patients older than 50 years, stages of compensation of diabetes were the following: HbA1c less than 7.0% - good control, 7,0-8,0% - satisfactory control, above 8.0% - poor control. Results: The amount of patients with HbA1c level under 7% was 8.65%, with HbA1c from 7.0 to 8.0% - 17.11%, with HbA1c above 8.0% - 74.24%, respectively. The average HbA1c level among clients with type 2 diabetes and insulin treatment was (9.62±0.07)% and among those, who used anti-diabetic drugs - (9.34±0.08)%, respectively. The average HbA1c concentration in patients with type 2 DM in Ternopil region, Ukraine in 2011 was (9.48±0.06)%. Conclusions: The average level of glycated hemoglobin in patients with type 2 diabetes mellitus in Ternopil region, Ukraine in 2011 was (9.48±0.06)%, and did not depend on the method of its treatment (insulin or anti-diabetic drugs). The majority of clients with diabetes mellitus type 2 (74.24%) presented poor control of the disease. |
||||||
| Cuvinte-cheie diabetes mellitus, glycated haemoglobin |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Autor, N.</dc:creator> <dc:creator>Mazur, L.</dc:creator> <dc:creator>Autor, N.</dc:creator> <dc:creator>Autor, N.</dc:creator> <dc:creator>Autor, N.</dc:creator> <dc:creator>Autor, N.</dc:creator> <dc:date>2012</dc:date> <dc:description xml:lang='en'><p>Introduction: WHO notes that diabetes mellitus (DM) leads to increased mortality of patients by 2-3 times and reduces their life duration by 10-30 %. Epidemiological studies in Ukraine indicate a permanent increase in the number of patients with both DM types. The most objective and long-term indicator of diabetes compensation is glycated hemoglobin (HbA1c). Purpose: Our study was to estimate the stage of compensation for patients with DM types 1 and 2 in Ternopil region on the basis of HbA1c levels. Materials and methods: We examined 285 patients with type 2 diabetes, among them 150 people received insulin therapy. The duration of diabetes was from 2 to 17 years. Patients’ age was from 42 to 75 years. Due to the fact that the study involved 49.2% of patients older than 50 years, stages of compensation of diabetes were the following: HbA1c less than 7.0% - good control, 7,0-8,0% - satisfactory control, above 8.0% - poor control. Results: The amount of patients with HbA1c level under 7% was 8.65%, with HbA1c from 7.0 to 8.0% - 17.11%, with HbA1c above 8.0% - 74.24%, respectively. The average HbA1c level among clients with type 2 diabetes and insulin treatment was (9.62±0.07)% and among those, who used anti-diabetic drugs - (9.34±0.08)%, respectively. The average HbA1c concentration in patients with type 2 DM in Ternopil region, Ukraine in 2011 was (9.48±0.06)%. Conclusions: The average level of glycated hemoglobin in patients with type 2 diabetes mellitus in Ternopil region, Ukraine in 2011 was (9.48±0.06)%, and did not depend on the method of its treatment (insulin or anti-diabetic drugs). The majority of clients with diabetes mellitus type 2 (74.24%) presented poor control of the disease.</p></dc:description> <dc:source>MedEspera () 60-60</dc:source> <dc:subject>diabetes mellitus</dc:subject> <dc:subject>glycated haemoglobin</dc:subject> <dc:title>Indicators of diabetes mellitus type 2 patients compensation by the level of glycated hemoglobin in ternopol region, Ukraine, 2011</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>
|
|
|
